- Benign Prostatic Hyperplasia
- Hormone Therapy
- Genomic Testing
- Next-Generation Imaging
- UTUC
- OAB and Incontinence
- Genitourinary Cancers
- Kidney Cancer
- Men's Health
- Pediatrics
- Female Urology
- Sexual Dysfunction
- Kidney Stones
- Urologic Surgery
- Bladder Cancer
- Benign Conditions
- Prostate Cancer
Dr. Sellinger on private equity acquisition in urology
“Private equity allows an opportunity to provide improved scale with large organization,” says Scott B. Sellinger, MD, FACS.
In this video, Scott B. Sellinger, MD, FACS, highlights the growing trend of private equity acquisition in urology. Sellinger is a urologist at Advanced Urology Institute, an independent, integrated urology practice in Tallahassee, Florida.
Video Transcript:
Private equity in urology has really blown up over the last few years. It has trailed behind some of the other specialties in medicine that have already had similar patterns, so we've learned some from them. We've learned what works and what doesn't work. That's one of the benefits that we have in not being the first in that group. It boils down to [the idea that] like-minded urologists like to be together and work together and continue to find better ways to provide best patient care. We're in a difficult situation right now where our business continues to grow, our workforce is shrinking, and our costs are going up, yet our reimbursements remain fixed or go down. So, we need to be creative and find other ways to have business models that work. Private equity allows an opportunity to provide improved scale with large organization. We can learn from each other in many ways, and I think that so far, it's been very helpful in all regards.
This transcription has been edited for clarity.
Medicare’s G2211 and thoughts on how to best use it in urology
May 1st 2024"We felt that it was important to again address this topic because we have received numerous questions regarding the correct use of this code and we have had some experience using the code now that it is active and been able to observe some of the initial payment processing by the payer," write Jonathan Rubenstein, MD, and Mark Painter.
Experts develop guide on online tools to reduce costs of urologic drugs
April 22nd 2024"At a time when patients are increasingly concerned about prescription drugs, this information will provide a useful starting point for making essential medications as affordable as possible," says Ruchika Talwar, MD.
